cd38 moa | Anti CD38 monoclonal antibodies for multiple myeloma treatm

Keyword	CPC	PCC	Volume	Score	Length of keyword
cd38 moa	0.94	0.1	686	92	8
cd38	0.03	0.7	2755	20	4
moa	0.57	1	1730	24	3

Keyword	CPC	PCC	Volume	Score
cd38 marker	0.99	0.3	6759	9
cd38 macrophage	0.16	0.7	6111	98
cd38 monoclonal antibody	1.91	0.8	4363	67
cd38 mab	1.08	0.1	9522	32
cd38 marqueur	1.71	0.8	9674	71
cd38 mouse	0.14	0.8	5170	60
cd38 monocyte	1.01	0.1	8413	32
cd38 molecular weight	1.44	0.7	8640	50
cd38 marker flow cytometry	1.57	0.6	6796	46
cd38 monoclonal antibody drugs	0.83	0.3	653	61
cd38 marker b cell	1.52	0.3	8031	11
cd38 marker cancer	0.61	0.5	6628	88
what is cd38 a marker for	1.43	0.1	9017	82
cd38 activation marker	1.64	0.5	4533	85
cd38 t cell marker	0.3	0.5	9209	72
cd38 cell marker	1.03	0.8	5072	53
cd38 tumor marker	0.83	0.7	6288	33
cd38 marker t cells	1.87	0.5	5007	69

Search Results related to cd38 moa on Search Engine

Anti CD38 monoclonal antibodies for multiple myeloma treatment
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225612/

WEBApr 11, 2022 · CD38 is a transmembrane glycoprotein with ectoenzymatic activity and is highly and uniformly expressed on multiple myeloma (MM) cells. CD38 is expressed also … DOI: 10.1080/21645515.2022.2052658 Published: 2022 Publication: Hum Vaccin Immunother. 2022; 18(5): 2052658.

DOI: 10.1080/21645515.2022.2052658
Published: 2022
Publication: Hum Vaccin Immunother. 2022; 18(5): 2052658.

DA: 87 PA: 99 MOZ Rank: 14

Mechanism of Action of a New Anti-CD38 Antibody: Enhancing …
aacrjournals.org

https://aacrjournals.org/clincancerres/article/25/10/2946/10672/Mechanism-of-Action-of-a-New-Anti-CD38-Antibody

WEBMay 15, 2019 · SAR650984, a novel humanized CD38-targeting antibody, demonstrates potent antitumor activity in models of multiple myeloma and other CD38+ hematologic …

DA: 43 PA: 28 MOZ Rank: 99

Anti CD38 monoclonal antibodies for multiple myeloma treatment
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225612/

DA: 95 PA: 62 MOZ Rank: 70

The Mechanism of Action of the Anti-CD38 Monoclonal Antibody …
aacrjournals.org

https://aacrjournals.org/clincancerres/article/25/10/3176/10772/The-Mechanism-of-Action-of-the-Anti-CD38

WEBMay 15, 2019 · The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma | Clinical Cancer Research | American Association for Cancer …

DA: 31 PA: 54 MOZ Rank: 46

CD38 antibodies in multiple myeloma: back to the future
ashpublications.org

https://ashpublications.org/blood/article/131/1/13/107710/CD38-antibodies-in-multiple-myeloma-back-to-the

WEBJan 4, 2018 · CD38 is a transmembrane glycoprotein with ectoenzymatic activity, and also functions as a receptor and adhesion molecule. Altogether, this has triggered the development of several CD38 …

DA: 82 PA: 82 MOZ Rank: 64

Critical Analysis on the Mechanism of Action (MoA) of the Anti …
ashpublications.org

https://ashpublications.org/blood/article/128/22/2105/100477/Critical-Analysis-on-the-Mechanism-of-Action-MoA

WEBDec 2, 2016 · Abstract. Monoclonal antibodies (mAbs) targeting CD38 are demonstrating remarkable efficacy, particularly when combined with anti-MM agents. Thus, in-depth …

DA: 48 PA: 76 MOZ Rank: 71

Daratumumab induces mechanisms of immune …
nature.com

https://www.nature.com/articles/s41375-020-0810-4

WEBApr 16, 2020 · Daratumumab (Dara), a multiple myeloma (MM) therapy, is an antibody against the surface receptor CD38, which is expressed not only on plasma cells but also on NK cells and monocytes. Correlative...

DA: 56 PA: 95 MOZ Rank: 64

Deep immune profiling of patients treated with lenalidomide and
nature.com

https://www.nature.com/articles/s41375-020-0855-4

WEBMay 26, 2020 · CD38-targeted antibody, daratumumab, is approved for the treatment of multiple myeloma (MM). Phase 1/2 studies GEN501/SIRIUS revealed a novel …

DA: 85 PA: 75 MOZ Rank: 22